---
figid: PMC12028784__marinedrugs-23-00145-g007
figtitle: This study
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12028784
filename: marinedrugs-23-00145-g007.jpg
figlink: /pmc/articles/PMC12028784/figure/F7/
number: F7
caption: Schematic overview of this study. Isaridin E inhibits the activation of the
  LPS-induced TLR4/NF-κB signaling pathway, thereby reducing the production of pro-inflammatory
  cytokines and alleviating vascular endothelial inflammation and tissue injury
papertitle: The Marine Compound Isaridin E Ameliorates Lipopolysaccharide-Induced
  Vascular Endothelial Inflammation via the Downregulation of the TLR4/NF-κB Signaling
  Pathway
reftext: Jing Liu, et al. Mar Drugs. 2025 Apr;23(4).
year: '2025'
doi: 10.3390/md23040145
journal_title: Marine Drugs
journal_nlm_ta: Mar Drugs
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: isaridin E | marine natural products | endothelial inflammation | TLR4 |
  NF-κB
automl_pathway: 0.9404678
figid_alias: PMC12028784__F7
figtype: Figure
redirect_from: /figures/PMC12028784__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12028784__marinedrugs-23-00145-g007.html
  '@type': Dataset
  description: Schematic overview of this study. Isaridin E inhibits the activation
    of the LPS-induced TLR4/NF-κB signaling pathway, thereby reducing the production
    of pro-inflammatory cytokines and alleviating vascular endothelial inflammation
    and tissue injury
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR4
  - IRF6
  - NFKBIA
  - NFKB1
  - CCL2
  - IL6
  - TNF
  - IL1A
  - IL1B
  - ICAM1
  - VCAM1
---
